Bain Capital Life Sciences Investors, LLC is a principal investment firm based in Boston, Massachusetts, focusing on investments in the life sciences sector. The firm specializes in various types of investments, including inflection capital, growth capital, buyouts, and turnaround investments. It targets biopharmaceutical, specialty pharmaceutical, medical device, diagnostics, and enabling life science technology companies worldwide. Bain Capital Life Sciences aims to support companies that drive medical innovation and address unmet medical needs, providing not only capital but also strategic assistance to enhance their growth and value during critical phases. The firm's unique expertise in the life sciences landscape allows it to effectively navigate complex investment opportunities and contribute to advancements in healthcare.
Room 3658-60, 36/F Two IFC 8 Century Boulevard Shanghai, 200120, China / 47/F Cheung Kong Center, 2 Quee' Road Central, Hong Kong
Darren Abrahamson
Managing Director
Ajay Agarwal
Partner
Thomas Allen
Principal
Eric Anderson
Managing Director and Member of the North American Private Equity Team
Ernesto Anguilla
Partner and Head of Communications and Public Affairs
Tim Anten
Managing Director and Member of the European Private Equity Team
Melaku Arega
Associate
Carlos Argilagos
Director
Emily Ashworth
Managing Director, Operating Partner of Portfolio Group and Member of the North American Private Equity team
Lorenzo Bartolini
Associate
James Bath
Operating Partner in the Portfolio Group and Member of the European Private Equity team
Jonathan Belitsos
Partner, Private Equity
Saahil Bhatia
Managing Director, Private Equity and Member of the Asia Pacific Private Equity team
William Bihrle
Managing Director, Technology, Media, Telecommunications and Private Equity and Member Of The North American Private Equity Team
Riker Bixby
Associate
Jakob Brevinge
Principal
Giovanni Camera
Partner, Technology Financial and Business Services and Member of the European Private Equity team
Phillip Carter
Managing Director
Richie Chaikof
Associate
Amit Chandra
Partner
Hunter Chang
Associate
Cecilia Chao
Partner, Double Impact Team
Bradley Charchut
Partner
Daniel Charnoff
Principal, Industrials and Member of the North American Private Equity Team
Shuvam Chaudhuri
Associate
Mary Chen
Associate
Daisy Chen
Managing Director
Leong Cheung
Operating Partner
John Paul (JP) Chilazi
Managing Director of Healthcare Vertical and Member of the North American Private Equity Team
Mike Choi
Managing Director, Private Equity and Member of the Asian Private Equity Team
Kevin Chong
Partner, Special Situations and Head of Special Situations Portfolio Group
Kei W. Chua
Partner, Special Situations
Tan Chuqiao
Partner
Davis Clayson Jr.
Managing Director
Alysaa Co
Associate
Stefan Cohen
Partner
Zeeza Cole
Principal
Amanda Conklin
Vice President, Double Impact
Todd Cook
Partner
Michael Cooney
Associate
Jay Corrigan
Group Co-CFO
Ryan Cotton
Managing Director
Pascal Croak
Investor
Leslie Crowe
Partner
David Cullen
Partner and Head of European Portfolio Group
Frank D'Hollander
Operating Partner
Jennie Daisak
Vice President
Jennifer Davis
Partner, Private Equity, Consumer and Retail Vertical and Member of the North American Private Equity Team
Nathaniel Denby
Vice President
Clarence Deng
Principal, Member of the Consumer and Technology verticals on the Asia Pacific Private Equity
David DesPrez
Managing Director, Special Situations
Wayne DeVeydt
Managing Director
Christina Dix
Partner, Healthcare Vertical and Member of European Private Equity team
Arnaud Doerane
Managing Director, Private Equity, Technology Financial and Business Services Vertical and Member of the European Private Equity Team
Jacob Donnelly
Partner
David B. Edelson
Managing Director, Portfolio Group
Erin Endres
Associate
Liraz Evenor
Managing Director Private Equity and Director in the Consumer and Retail Vertical & Member of the Portfolio Group for North America Private Equity
Robert Farkas
Partner, Private Equity and Member of the North American Private Equity Team
Leonard Feiner
Principal
Valentin Fernandez
Principal, Private Equity and Member of the North American Private Equity Team
William Van Fossen
Associate
Jorge Fournier
Vice President
Michel Freund
Partner and Member of the North American Private Equity Team
Scott Friend
Partner
Rak Garg
Partner
Nick Gattas
Principal, Asian Pacific Private Equity team
Francois Gilbart
Operating Partner, Private Equity
Evan Greif
Principal, Life Sciences
Max de Groen
Partner, Private Equity
Kevin Guan
Managing Director
Soren Haefcke
Principal
Dave Hamilton
Partner and Co-Head of Information Technology
Ingrid Hammond
Operating Partner, Portfolio Group and Member of the North American Private Equity Team
Kristie Han
Principal
Matt Harris
Partner
Alena Harrison
Operating Partner
Joshua Hartz
Partner, Special Situations
Ray Hass
Managing Director and Member of the Asia Pacific Portfolio Group
Aaref Hilaly
Partner
Sarah Hinkfuss
Partner
Alison Holmes
Principal, Private Equity and Consumer, Retail and Dining Vertical & Member of the North American Private Equity Team
Ben Holzman
Managing Director
Halvor Meyer Horten
Partner, Industrials Vertical and Member of the European Private Equity team
Merritt Hummer
Partner
David Humphrey
Partner, Global Head of the Technology, Media and Telecommunications Vertical and Co-Head of Bain Capital's North American Private Equity
Jonathan Humphrey
Managing Director, Global Macro and Asset Allocation group
Abhiroop Jayanthi
Managing Director and Member of the Asian Pacific Private Equity team
Cristian Jitianu
Partner, Private Equity, Consumer, Retail and Dining and Financial and Business Service Verticals
Philippe Kamel
Principal of European Private Equity Team
Masafumi Kamishiro
Operating Partner, Portfolio Group and Member of the Asian Pacific Private Equity team
Andrew Kaplan
Partner, Private Equity and Healthcare Vertical and Member Of The North American Private Equity Team
Christopher Kastner
Operating Partner
Nick Kazarinoff
Principal, Healthcare Vertical and Member of the European Private Equity Team
James Kellog
Managing Director
Liam Kennedy
Partner and Corporate Controller
Kevin Kerby
Managing Director, Private Equity and Member of the North American Private Equity Team
Victoria Khanna
Partner, Investor Relation
Tomohiro Kikuta
Partner
Hyunseung Kim
Managing Director, Portfolio Group and Member of the Asian Pacific Private Equity Team
Takatoshi Kojima
Principal, Private Equity and Member of the Asia Pacific Private Equity Team
Hayato Kondoh
Principal and Member of the Asia Pacific Private Equity team
Joshua de Kroes
Principal, Industrials and Member of the European Private Equity
Hisashi Kubodera
Principal and Member of the Asian Pacific Private Equity Team
Ajay Kumar
Managing Director, Private Equity, Industrial and Energy Vertical and Member Of The North American Private Equity Team
Christina Kyriazi
Partner
Komi Kyu
Managing Director and Member of the Asia Pacific Private Equity Team
Jungwoo Lee
Partner, Industrial and Technology, Media and Telecommunications and Member of the Asia Pacific Private Equity and Special Situations teams
Casey Leonetti
Operating Partner
Susan Levine
Partner, Private Equity and Member Of The North American Private Equity Team
Angela Liu
Associate
Carolyn Liu
Managing Director
Andrew Liu
Executive Vice President of Asia Portfolio Group
Zihan Liu
Principal
Phillip Loughlin
Partner, Global Head of the Financial and Business Services Vertical and Member of the Consumer / Retail Vertical
Benjamin Lund
Partner
James Mackey
Principal, Private Equity and Technology Vertical and Member of the North American Private Equity Team
Francesco Marra
Managing Director, Portfolio Group and Member of the European Private Equity team
Giacomo Massetti
Managing Director, Consumer and Industrial Verticals and Member of the European Private Equity team
Kimberly McCaslin
Partner, Private Equity and Head of the North America Portfolio Group
Christophe Jacobs van Merlen
Managing Director
Greg Mervine
Associate
Abby Meyers
Principal
Grace Mollard
Managing Director, Consumer, Retail and Restaurant Vertical and Member Of The North American Private Equity Team And Recruiting Team
Sarah Morris
Managing Director of Portfolio Group and Member of the European Private Equity Team
Paul Moskowitz
Managing Director, Private Equity and Healthcare Vertical and Member Of The North American Private Equity Team
Colin Motley
Managing Director, Technology, Media, Telecom Vertical and Private Equity and Member Of The North American Private Equity Team
Mike Murphy
Partner, Private Equity
Shunsuke Nakahama
Partner and Member of the Portfolio Group for the Asia Pacific Private Equity
Cara Nealon
Senior Vice President, Portfolio Group and Member of the North American Private Equity Team
Adam Nebesar
Partner, Private Equity and Consumer, Retail and Dining Vertical and Member Of The North American Private Equity Team
Petr Nosek
Principal
Devin O'Reilly
Partner, Private Equity and Head of the Healthcare Vertical
Kazunari Obama
Principal, Private Equity Tokyo
Martha Obasi
Vice President
Saanya Ojha
Partner
Fatima Porras Olalla
Principal, European Private Equity Team
Nicholas Onie
Principal of Asia Pacific Private Equity Team
Kenichi Ota
Principal, Private Equity and Member of the Asia Pacific Private Equity Team
Kohei Otani
Principal, Asia Pacific Private Equity Team
Jie Pan
Operating Partner
Minju Park
Principal, Special Situations
Hardi Patel
Associate
Sam Payne
Principal, Private Equity and Member of the Asian Pacific Private Equity Team
Dwight Poler
Managing Director
Benjamin Prawdzik
Vice President, Consumer and Financial and Business Services Verticals
Marc Pulde
Principal, Industrial and Energy Vertical and Member Of The North American Private Equity Team
Chen Qian
Managing Director and Member of the Asian Pacific Private Equity Team
Larissa Quinn
Operating Partner
Gianni Renzi
Associate
Peter Riehl
Managing Director
Allyson S. Rinderle
Managing Director
Joseph Robbins
Partner, Private Equity and Industrial Vertical and Member of the North American Private Equity Team
Mitt Romney
Founder
Joshua Ross
Managing Director
Douglas Rudisch
Managing Director
Mark Saadine
Managing Director of Consumer, Retail and Dining Vertical and Member of the North American Private Equity Team
Jeremie Saiman
Principal of European Private Equity Team
Youssef Salha
Partner, Private Equity and Member of the European Private Equity team
Tom Sargeant
Partner
Matt Sears
Principal
Dominik Seitz
Principal
Hans Sherman
Partner
Ari Singer-Freeman
Associate
Pavninder Singh
Partner, Private Equity, Financial and Business Services and Industrial and Energy Verticals and Member Of The Asian Pacific Private Equity Team
David Spiller JD
Partner of Portfolio Group and Member of the North American Private Equity Team
Peter Spring
Partner, Double Impact
David Steiner
Vice President of Real Esate
Slater Stich Ph.D
Partner
Zhao Su
Principal
Pooja Subramaniam
Associate
Radhika Subramanian
Principal, Consumer, Retail and Financial services and a Member of the Asia Pacific Private Equity team
Mark Sutton
SVP and Chief Information Security Office
Junichi Takami
Executive Vice President, Portfolio Group and Member of the Asian Pacific Private Equity team
Yuji Takei
Partner, Private Equity
James Tam
Partner and Managing Director, Private Equity Team, Greater China
Will Tetler
Managing Director, Special Situations
Aurelia Tichoux
Operating Partner of Portfolio Group and Member of the European Private Equity Team
Miray Topay
Partner, Private Equity
John Toussaint
Managing Director
Pierre-Henri Vacher-Lavenu
Principal
Davide Vidotto
Principal, Private Equity and Member of the European Private Equity team
Shunsuke Wakita
Principal and Member of the Asian Pacific Private Equity Team
Nigel Walder
Managing Director
Danielle Wang
Operating Partner of Portfolio Group Portfolio Group and Member of the North American Private Equity Team
Renjie Wang
Managing Director and Member of the Asia Pacific Private Equity Team
Shun Watanabe
Managing Director, Portfolio Group and Member of the Asian Pacific Private Equity team
Harris Weber
Principal
Sam Weil
Principal, Private Equity and Member Of The North American Private Equity Team
Phil Wieland
Operating Partner
Shena Willis
Principal, Private Equity and Member of the European Private Equity Team
ELi Winkler
Managing Director, Private Equity
Patricia Winton
Partner, Global Head of ESG
Natalie Wright
Partner and Head of Investment Operations, Private Equity
Ray Xi
Managing Director
Takumi Yoshikawa
Operating Partner and Member of the Asian Pacific Private Equity Team
Martina Yu
Principal, Private Equity and member of the Asian Pacific Private Equity team
Amanda Zajac
Investor
Lina Zhou
Principal, Private Equity, Consumer, Retail and Dining vertical and Member of European Private Equity team
Jack Zhu
Vice President
Paul Zurlo
Partner and COO
Charles Megaw Ph.D
Partner, Private Equity and Member of Portfolio Group for Europe Private Equity
Zhenyu Zhang Ph.D
Managing Director and Member of the Asian Pacific Private Equity Team
1005 past transactions
Astronomer
Series D in 2025
Astronomer, Inc. is a company based in Cincinnati, Ohio, that specializes in developing a managed platform for data orchestration, primarily utilizing Apache Airflow. Established in 2014, Astronomer offers a comprehensive suite of products and services through its platform, known as Astro. This platform is designed to streamline the process of building, running, and monitoring data pipelines-as-code, catering to the needs of data engineers, scientists, and analysts. By providing tools for deploying, managing, and scaling data workflows, Astronomer enhances the availability of trusted data for organizations, making it easier for data teams to conduct business analytics effectively. As a commercial developer of Airflow, Astronomer plays a significant role in the data orchestration landscape, serving hundreds of thousands of teams globally.
Structify
Seed Round in 2025
Structify scans any data source on the internet to create a custom dataset. Customers use it to create data processes by specifying the data format, selecting on the source(s), and assigning agents to search and extract the data. The company's in-house model ensures quality and accuracy across all use cases. Structify has already experienced widespread application in finance, construction, and corporate technology. For example, finance teams can submit pitch decks and extract the company name, industry, founders, investors, and fundraising amount from each one. Construction teams use it to convert geotechnical documents into comprehensible tables. Sales and operations teams receive real-time chain of command data for their accounts, allowing them to speed up their pipeline.
Navro
Series B in 2025
Navro specializes in providing payment and banking infrastructure tailored for software companies. The company has developed a fintech platform that enables brands to scale their payment operations on a global scale. Navro offers a range of services, including customizable checkout solutions, integration of various payment acceptance methods, local fund collection, and real-time payment stack management. This comprehensive approach allows businesses to efficiently manage their payments infrastructure, facilitating international growth and ensuring that companies can receive funds in their preferred methods.
BitradeX
Series A in 2025
BitradeX is a digital asset trading platform powered by AI technology, dedicated to redefining digital asset trading through innovative AI algorithms and blockchain technology.
Lincoln Financial Group
Post in 2025
Lincoln Financial Group is a Fortune 500 insurance and financial services company based in Radnor, Pennsylvania, established in 1905 with the endorsement of Robert Todd Lincoln, the son of Abraham Lincoln. The company is dedicated to providing a wide range of products, including life insurance, annuities, retirement plan services, and group protection. It focuses on wealth protection, accumulation, and retirement income solutions, aiming to help individuals secure better futures for themselves and their families. With over a century of experience, Lincoln Financial Group has built its reputation on the principles and ideals associated with Abraham Lincoln, emphasizing honesty and dependability in its financial services.
Sizzling Platter
Acquisition in 2025
Sizzling Platter, LLC is a food and beverage company that owns and manages a diverse range of fast casual restaurants in the United States and internationally. Founded in 1963 and headquartered in Murray, Utah, the company offers a variety of menu items, including pizzas, donuts, coffee, burgers, steak, seafood, and salads. Sizzling Platter focuses on acquiring and supporting various restaurant brands, providing them with the resources needed for growth and enhanced return on capital. The company is committed to delivering a quick service and casual dining experience at affordable prices, while also engaging in community initiatives such as donating food to those in need.
Merida Biosciences
Series A in 2025
Merida Biosciences is a new biotech company focused on developing precision treatments, particularly for autoimmune diseases. The company utilize a protein engineering platform to create unique Fc therapeutics, aiming to selectively bind to specific antibodies.
HealthEdge
Acquisition in 2025
HealthEdge is a technology company that provides an integrated software platform designed for healthcare payors. Founded in December 2004 by Albert Waxman and Rob Gillette, HealthEdge specializes in delivering innovative solutions that help health insurers enhance operational efficiency, improve patient outcomes, and significantly lower administrative costs. The company's flagship product suite, HealthRules, is built on patented technology and can be deployed via the HealthEdge Cloud or on-premises. This platform encompasses various functionalities, including claims and benefits administration, care management, and business intelligence, enabling clients to adopt new business models and streamline processes within the healthcare delivery system. In 2012, HealthEdge expanded its offerings by acquiring Click4Care, which enhanced its capabilities in clinical care management. Headquartered in Burlington, Massachusetts, HealthEdge also has a research and development center in Powell, Ohio.
KREA
Series B in 2025
KREA operates an artificial intelligence platform that enables users to create images from text prompts and save them in personalized collections. The platform allows users to train a tailored AI using their own images, adapting it to individual styles. Additionally, KREA provides access to millions of AI-generated images, offering inspiration and insight for various projects.
Atsena Therapeutics
Series C in 2025
Atsena Therapeutics is a clinical-stage gene therapy company focused on developing treatments for inherited retinal diseases that can lead to blindness. Their clinical pipeline includes therapies for conditions such as X-linked retinoschisis and GUCY2D-associated Leber congenital amaurosis. Atsena employs an adeno-associated virus (AAV) technology platform, including a novel spreading capsid, to specifically target these retinal disorders. The company aims to prevent vision loss caused by genetic mutations through innovative ocular gene therapy solutions. With a commitment to advancing treatments for some of the most challenging forms of inherited retinal disease, Atsena Therapeutics seeks to improve the lives of patients affected by these conditions.
Actively AI
Series A in 2025
Actively AI, founded by Stanford AI researchers, specializes in an artificial intelligence-driven outbound sales platform that enhances lead generation and prospecting efficiency for sales teams. The platform offers features such as automated account research, real-time identification of top prospects, and personalized messaging generation based on data insights. By utilizing these capabilities, organizations can significantly increase their sales pipeline and improve meeting booking rates, enabling sales representatives to focus more on engaging with potential clients.
LightSource
Series A in 2025
LightSource develops a supply chain management platform to help professionals collaborate with their suppliers. It also allows collaborating with teammates on strategic sourcing projects, sending RFQs to suppliers and collecting quotes, and comparing bids using insights automatically extracted from the normal day-to-day work. The company was founded in 2021 and is headquartered in San Francisco, California.
Straiker
Series A in 2025
Straiker builds AI-native security solutions tp protect customers from a spectrum of security & safety risks.
Namirial
Acquisition in 2025
Namirial is a developer of digital transaction management software that facilitates the complete digital transformation of business processes for private sector companies and public administration organizations. The company's platform encompasses a range of services, including identity management, electronic signatures, certified communication, document management, electronic invoicing, and cybersecurity. By integrating these solutions, Namirial enables organizations to efficiently manage and execute both internal and external document-centric transactions in a fully digital environment, enhancing operational efficiency and security.
HeartFlow
Convertible Note in 2025
HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.
Silna Health
Series A in 2025
Silna Health builds proactive tools that handle all prior authorizations, benefit checks and insurance monitoring upfront to make sure patients are actually clear to receive care.
Manappuram Finance
Post in 2025
Manappuram Finance Limited is a non-banking financial company based in Thrissur, India, established in 1949. The company specializes in providing a diverse range of retail credit products and financial services, primarily focusing on loans secured by household and used gold jewelry. Its offerings include microfinance loans for low-income individuals, housing loans for construction and improvement, vehicle loans, and loans for the hospitality sector. Additionally, Manappuram Finance provides life and non-life insurance products, IT solutions, and various financial services such as money transfers and foreign exchange. With a significant presence, the company operated 3,531 branches across 23 states and 5 union territories as of March 31, 2020. Formerly known as Manappuram General Finance and Leasing Limited, it rebranded in 2011. The company is led by Shri V.P. Nandakumar, who holds a substantial equity stake.
Norm AI
Series B in 2025
Norm AI offers an AI-driven regulatory compliance platform tailored for the legal and compliance sectors. The platform addresses the regulatory sludge problem by transforming complex regulations into AI agents capable of making autonomous compliance decisions. This allows compliance teams to assign tasks to the regulatory AI using high-level instructions, while ensuring the quality of the output through validation at various levels of detail. Norm AI’s innovative solutions streamline compliance processes, improving efficiency and accuracy for organizations navigating intricate regulatory landscapes.
CMIC Holdings
Acquisition in 2025
CMIC Holdings is a Japan-based company founded in 1992 and headquartered in Minato-ku, Tokyo. It operates primarily as a contract research organization (CRO) and offers a diverse range of services tailored to the pharmaceutical and healthcare sectors. These services include contract development and manufacturing (CDMO), contract sales organization (CSO) support, and innovative pharmaceutical models (IPM). CMIC specializes in various aspects of pharmaceutical management, encompassing data management, statistical analysis, medical consulting, medical writing, auditing, and analytical testing. Additionally, the company plays a vital role in facilitating clinical trials and providing human resource services, as well as sales and marketing support, thereby contributing significantly to advancements in medical and healthcare fields.
Charta
Seed Round in 2025
Charta Health is an AI-powered platform that optimizes medical billing and coding workflows. Each chart undergoes a pre-bill review, which helps Charta Health find missed coding opportunities, avoid claim denials, and guarantee billing standards are followed.
Surf Internet
Private Equity Round in 2025
Surf Internet offers fiber and fixed wireless broadband services to residential and business customers in Indiana, Illinois, and Michigan. The company provides a variety of internet plans tailored to different usage needs, ensuring reliable connectivity for activities such as streaming, gaming, and remote work. In addition to broadband internet, Surf Internet also offers digital phone services. The company is committed to expanding its network infrastructure to improve service availability and performance while prioritizing customer support for installation and technical issues. Through its efforts, Surf Internet aims to enhance the quality of life in the Great Lakes region by delivering high-speed internet solutions to communities.
Hightouch
Series C in 2025
Hightouch is a customer data platform that specializes in data synchronization between various marketing and operational tools. The company enables businesses to connect their existing data warehouses with applications such as customer relationship management systems, email marketing platforms, and advertising networks. By providing a user-friendly interface, Hightouch simplifies data integration and management, allowing organizations to access and utilize their data effectively without duplication. This approach helps maintain data integrity and security, while empowering clients to leverage their data for personalized marketing campaigns. Hightouch's platform features audience segmentation, data transformation, and automated workflows, which assist businesses in optimizing their marketing strategies and operational processes.
Solid Biosciences
Post in 2025
Solid Biosciences Inc. is a life science company focused on developing therapies for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys. The company's lead product candidate, SGT-001, is a gene transfer therapy currently undergoing a Phase I/II clinical trial aimed at restoring functional dystrophin protein expression in patients' muscles. In addition to SGT-001, Solid Biosciences is advancing the Anti-LTBP4 program, which involves a monoclonal antibody designed to reduce fibrosis and inflammation by targeting the LTBP4 protein. The company also develops biomarkers and sensors, as well as the Solid Suit program, which focuses on creating wearable assistive devices with functional and therapeutic benefits. Founded in 2013 and headquartered in Cambridge, Massachusetts, Solid Biosciences has established a strategic collaboration with Ultragenyx to enhance gene therapy development for DMD. With no current cure for DMD, the company aims to provide innovative solutions for a condition that affects an estimated 10,000 to 15,000 cases in the United States.
Dream Security
Series B in 2025
Dream Security is a cybersecurity company that develops AI solutions to protect against cyber threats. The company provides various cybersecurity services, including AI-driven threat detection to monitor network activity for anomalies, incident response teams to manage and analyze cyber incidents, and vulnerability management through regular assessments and penetration testing. They also offer security awareness training, assist with compliance and risk management to meet regulatory requirements, and provide cloud security solutions for cloud infrastructures. Additionally, the company offers consulting services to help organizations develop and implement cybersecurity strategies.
Apleona
Acquisition in 2025
Apleona is an integrated real estate service provider operating primarily in the DACH region, offering a comprehensive range of services to banks, investment funds, industrial firms, and insurance companies. Established in 2016 and headquartered in Neu Isenburg, Hessen, the company specializes in technical facility services, including facility management, building technology, and interior fittings. Apleona's offerings extend to real estate management, encompassing commercial services such as letting, leasing, and marketing of properties. With a focus on enhancing performance across national borders, Apleona aims to meet the diverse needs of its clients in the real estate sector.
Abcuro
Series C in 2025
Abcuro, Inc. is a biotechnology company focused on developing immunotherapies for the treatment of autoimmunity and cancer. Based in Newton, Massachusetts, Abcuro creates therapeutic antibodies targeting novel mechanisms related to these diseases. The company utilizes advanced bioinformatics to analyze transcription data from human diseases, which aids in the identification of new therapeutic targets. Through ex-vivo validation in diseased tissues, Abcuro seeks to uncover innovative methods to modulate key components of the immune system. Established in 2015, Abcuro aims to enhance treatment strategies in the healthcare industry by offering effective solutions for complex immunological conditions.
Index
Seed Round in 2025
The product-native discovery companion for Linear. Collect feedback, brainstorm ideas, and manage product plans.
SelectQuote
Post in 2025
SelectQuote Insurance Services, Inc. is an insurance company based in San Francisco, California, specializing in a diverse array of insurance products, including term life, auto, home, and Medicare insurance. Founded in 1985, SelectQuote aims to assist families by providing tailored insurance solutions that meet their specific needs and budget. Operating as a subsidiary of SelectQuote, Inc., the company utilizes a direct-to-consumer distribution model, allowing clients to compare rates from a wide range of highly rated insurance providers online. This approach ensures that consumers receive the best possible coverage at competitive prices. SelectQuote generates revenue through commissions earned by selling insurance products on behalf of its carrier partners and operates through four key segments: Senior, Healthcare Services, Life, and Auto & Home.
Mitsubishi Tanabe Pharma
Acquisition in 2025
Mitsubishi Tanabe Pharma Corporation is a pharmaceutical company headquartered in Osaka, Japan, that manufactures and sells a diverse range of drugs across Japan, Europe, North America, and other Asian countries. The company focuses on developing treatments for various medical conditions, including immuno-inflammation, diabetes, kidney diseases, and central nervous system disorders. Its notable products include Simponi for rheumatoid arthritis, multiple diabetes treatments such as Canaglu and Invokana, Radicava for amyotrophic lateral sclerosis, and Gilenya for multiple sclerosis. Additionally, Mitsubishi Tanabe Pharma offers vaccines, including influenza and varicella vaccines, and over-the-counter products. The company collaborates with several organizations to enhance its research and development capabilities. Founded in 1678, it operates as a subsidiary of Mitsubishi Chemical Holdings Corporation.
Milacron Holdings
Acquisition in 2025
Milacron Holdings is a prominent manufacturer and distributor of highly engineered and customized systems within the plastic technology and processing industry, which is valued at approximately $27 billion. The company offers a comprehensive product portfolio that includes injection molding, blow molding, extrusion equipment, and hot runner systems, positioning itself as the only global entity with such a full-line offering. Milacron's operations are divided into three segments: Advanced Plastic Processing Technologies, Melt Delivery and Control Systems, and Fluid Technologies. The Advanced Plastic Processing Technologies segment focuses on the design and manufacture of various molding equipment and related services, while the Melt Delivery and Control Systems segment produces hot runner and process control systems, along with maintenance, repair, and operating supplies for plastic processing equipment. The Fluid Technologies segment specializes in synthetic and semi-synthetic lubricants and coolants for industrial metalworking applications. With a diverse customer base exceeding 27,000, Milacron maintains strong market shares in North America and emerging markets like China and India.
MagicSchool
Series B in 2025
MagicSchool provides various AI tools to assist teachers with their diverse tasks. It is a comprehensive platform designed to support teachers in multiple facets of their profession, including lesson planning, assessment creation, differentiation, communication, and beyond. Utilizing over 60 AI tools, it generates original and tailored educational content, feedback, and recommendations.
Archive
Series B in 2025
Archive is a technology company that specializes in creating customized resale programs for brands, helping them manage their secondhand markets effectively. By partnering with notable brands, Archive designs tailored resale experiences that extend the lifecycle of clothing and generate additional revenue streams. The company leverages its advanced technology and logistics capabilities to facilitate various resale models, including peer-to-peer sales, product take-backs, and brand-owned inventory management. Through its proprietary software, Archive empowers brands to launch comprehensive resale businesses that not only enhance customer loyalty but also attract new customers, all while aiming to reduce the environmental impact of the fashion industry.
Frontline Road Safety
Acquisition in 2025
Frontline Road Safety provides pavement marking services to a variety of end markets and customers. It's companies provide a range of services, including seal coating, pressure washing, and parking lot striping. The company was formed in 2020 by the private equity firm Sterling Group.
Dhoot Transmission P
Private Equity Round in 2025
Dhoot Transmission Pvt. Ltd. is an Indian conglomerate specializing in the manufacture and provision of various automotive components, including wiring harnesses, electronic sensors, controllers, and automotive switches. The company also produces power cords and offers solutions for cable systems, copper wires, and tooling for electronics, stamping, and molding systems. With 23 manufacturing facilities worldwide, Dhoot Transmission serves a diverse customer base across eight countries and three continents. The company is ISO certified and has expanded its operations through strategic acquisitions within the industry. During the COVID-19 pandemic, Dhoot Transmission successfully resumed operations while adhering to health and safety guidelines.
Jamco
Acquisition in 2025
Jamco is a Japan-based manufacturer specializing in components for the aviation industry. The company operates through several business divisions, including Aircraft Interiors, Aircraft Seats, Aircraft Components, and Aircraft Maintenance. Its Aircraft Interiors division produces items such as galleys and lavatories for passenger aircraft, while the Aircraft Seat division focuses on the manufacturing and sales of passenger seats. The Aircraft Components division is involved in the production of critical engine components, including heat exchangers and various aircraft equipment. Additionally, the Aircraft Maintenance division provides maintenance and alteration services to ensure the safety and efficiency of aircraft operations. Jamco is committed to enhancing air travel comfort and safety through its innovative technologies and high-quality products.
Timberlyne Therapeutics
Series A in 2025
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on promising targets, and implementing them in disease areas with considerable unmet needs.
Cofactr
Series A in 2024
Cofactr, founded in 2021 by Matthew Haber and Phillip Gulley in New York, specializes in supply chain automation and procurement optimization for critical industries such as aerospace, defense, medtech, and robotics. The company offers an automated electronics purchasing assistant that aids hardware teams in sourcing necessary components by connecting them with global suppliers. Cofactr's platform features powerful supply chain intelligence, intuitive forecasting, transparent search capabilities, automated quoting, and instant purchasing. By streamlining these processes, Cofactr enables clients to proactively address sourcing challenges and reduce supply issues, ensuring the timely delivery of essential hardware.
Mayapada Hospital
Post in 2024
Mayapada Hospital offers health and hospital management services. They provide a range of services ranging from diagnosis, therapy, surgery, and rehabilitation to comprehensive care and control of neurological disorders. They offer clinical services and medical consultations for digestive tract problems. Their paediatric centre also provides physical check-ups, vaccinations, and treatment for specific paediatric symptoms, heart failure, and orthopaedic disorders.
Angitia Biopharmaceuticals
Series C in 2024
Angitia Biopharmaceuticals is a global biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. The company focuses on researching and creating breakthrough therapies aimed at treating conditions affecting bones, muscles, and joints. By prioritizing the development of novel drugs, Angitia Biopharmaceuticals aims to improve patient outcomes and facilitate recovery from severe musculoskeletal ailments.
Pollo Tropical
Debt Financing in 2024
Pollo Tropical has been committed to providing fresh, great-tasting dishes in its kitchens every day. Authentic preparation, fresh ingredients, and a creative touch on traditional flavors are the perfect mix for delicious, craveable food.
Wrightwell
Private Equity Round in 2024
Wrightwell operates as a services platform that offers customizable, institutional access to a multi-trillion-dollar asset class to investors of all types and sizes. The company's services are primarily focused on asset management, construction, financial services, and real estate. Vantage's Single Family Rental (SFR) Services, backed by proprietary technology, empower investors to make SFR a significant part of their portfolio. The company also assists clients in determining leasing criteria and guidelines, such as background checks, employment documentation, and credit score minimums.
Olema Oncology
Post in 2024
Olema Oncology is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for estrogen receptor (ER) positive breast cancer. The company specializes in the discovery and commercialization of targeted treatments aimed at improving outcomes for women with cancer. Olema utilizes its extensive knowledge of endocrine-driven cancers and the molecular mechanisms of the ER to create drug candidates that are designed to outperform existing therapies. Currently, the company's product pipeline includes OP-1250 and OP-3136, both of which have completed discovery and preclinical studies. Olema's mission is to transform the standard of care for both pre- and post-menopausal women by providing more effective and convenient treatment options.
Oak Reinsurance
Seed Round in 2024
OAK Re is an international provider of reinsurance.
Halcyon
Series C in 2024
Halcyon is a cybersecurity company focused on protecting enterprise clients from ransomware threats. It provides a platform that integrates layered ransomware protection, utilizing pre-execution detection, behavioral modeling, and deception techniques. This comprehensive approach aims to enhance the resilience of its clients, facilitating recovery and isolation of affected nodes. Halcyon primarily serves mid-market and enterprise customers, ensuring they are equipped to mitigate the risks associated with ransomware attacks.
VISO TRUST
Venture Round in 2024
VISO Trust is a San Francisco-based company founded in 2016 that specializes in vendor security due diligence. The company has developed a platform that provides comprehensive and actionable information regarding vendor security risks. This platform enables decision-makers to conduct informed risk assessments and make sound security choices by streamlining the vendor review process. By delivering reliable data, VISO Trust assists enterprises in managing third-party security risks effectively and transparently, ultimately enhancing their overall cybersecurity posture.
Northflank
Series A in 2024
Northflank Ltd. is a London-based company that specializes in developing a next-generation cloud hosting platform designed for developers. Founded in 2013, Northflank offers a self-service platform that allows users to build, run, and scale applications efficiently. The platform supports various workloads and is compatible with multiple cloud providers, facilitating seamless deployment and management of applications. Additionally, Northflank provides an automated development operations solution that includes integrated continuous integration, delivery, and deployment services, as well as data processing and hosting capabilities. This comprehensive offering aims to reduce costs and enhance operational effectiveness for organizations utilizing cloud services at scale.
Lean Technologies
Series B in 2024
Lean Technologies Limited, founded in 2019 and based in Riyadh, Saudi Arabia, is a FinTech startup that specializes in providing an application programming interface (API) platform for financial data applications. The company's API suite simplifies access to consumer financial data, allowing businesses to navigate the complexities of financial infrastructure with ease. By enabling seamless access to customers' financial information and facilitating instant bank transfers, Lean Technologies aims to enhance the accessibility, transparency, and utility of financial data and payments. This approach fosters a more inclusive and interconnected financial landscape, ultimately benefiting both consumers and businesses.
AQ Compute
Acquisition in 2024
AQ Compute provides green and customized compute capacities powered by clean energy. The company was founded in 2020 and is based in Hamburg, Germany.
The Openwork Partnership
Private Equity Round in 2024
The Openwork Partnership is a provider of financial advice services.
Decagon
Series B in 2024
Decagon offers AI customer support agents designed for enterprises. It is trusted by leading companies and startups, their generative AI delivers exceptional customer experiences. It provides auto-resolve issues, streamlines workflows, assists agents and gains powerful insights with seamless integrations tailored for success.
EvenUp
Series D in 2024
EvenUp is a legal tech company specializing in cloud-based and AI-driven solutions for personal injury legal practices. The company develops a platform that streamlines legal case management, focusing on valuing personal injury claims and automating document generation. Utilizing its Claims Intelligence Platform™, which leverages extensive data records, EvenUp enhances the performance of legal cases at various stages. The platform incorporates machine learning and artificial intelligence to assess the worth of lawsuits, providing funding for cases that only require repayment upon winning. This approach helps plaintiffs avoid premature settlements and financial burdens while equipping attorneys with valuable data for informed settlement negotiations.
Pallet
Series A in 2024
Pallet develops supply chain software that provides comprehensive visibility, automation, control, and optimization for end-to-end logistics. Its flagship product integrates a Transportation Management System (TMS) and Warehouse Management System (WMS), designed to streamline and enhance business operations.
Kailera Therapeutics
Series A in 2024
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases. Kailera Therapeutics is advancing a range of injectable and oral GLP-1 (Glucagon-like peptide-1) therapies for obesity and related diseases.
T-Gaia
Acquisition in 2024
T-Gaia is a telecommunications company based in Japan that operates primarily in three segments: Mobile, Solution, and Settlement Services. The company engages in the sales and distribution of mobile phones and offers corporate customers various solution services, including brokerage services for fixed-line communication and broadband services. T-Gaia has a significant presence in the prepaid market, selling prepaid cards and codes, primarily through convenience stores, which have been steadily expanding. Additionally, the company provides a nationwide electronic payment system and distributes gift cards in Singapore through its subsidiaries.
Zenlytic
Series A in 2024
Zenlytic is a business intelligence platform that leverages advanced technology to streamline data analysis for businesses. It features Zoë, a data analyst chatbot that significantly reduces ad hoc data requests and provides rapid responses, performing tasks up to 1200 times faster than traditional data teams. The platform enables users to pull data, create dashboards, and conduct advanced analytics using plain English, making complex data interactions more accessible. Zenlytic's innovative approach includes building a unique, LLM-native semantic layer that is integrated with a powerful AI agent and a modern business intelligence tool. Additionally, the platform serves as a centralized hub for e-commerce analytics, offering a no-code solution that automatically identifies important data changes and delves into the underlying causes of key metrics, allowing clients to gain a comprehensive understanding of their business performance.
Serán Bioscience
Private Equity Round in 2024
Serán Bioscience is a contract development and manufacturing organization that specializes in providing a wide range of services to pharmaceutical and biotechnology companies. The company offers a comprehensive suite of development, analytical, and clinical manufacturing services, aimed at optimizing drug development and production processes. By catering to various aspects of pharmaceutical development, Serán Bioscience supports its clients in efficiently bringing their products to market.
Digital Media Solutions
Private Equity Round in 2024
Digital Media Solutions is a leading performance marketing company that leverages actionable data, insightful analytics, and proprietary technology to help clients reach, engage, and acquire customers across various interactive platforms. With a focus on precision targeting and customer acquisition, DMS caters to top brands in competitive industries, offering a range of performance marketing, digital agency services, and marketing technology solutions. Through meticulous execution and a suite of proprietary assets, Digital Media Solutions delivers effective marketing strategies to drive client success.
Mintlify
Series A in 2024
Mintlify is a company that offers an AI-powered platform designed to assist developers in creating engaging and well-structured documentation for their products. By leveraging artificial intelligence, Mintlify automates the generation of documentation directly from code, allowing developers to focus on their core tasks without the burden of manual documentation. The platform is designed to be user-friendly and developer-centric, facilitating the creation of attractive public-facing documentation that enhances user experience and helps customers better understand the products. With over 7,000 companies, including notable names like Anthropic and Zapier, relying on its services, Mintlify aims to streamline the documentation process, ultimately saving time and improving the overall quality of documentation.
AutoComplete
Seed Round in 2024
AutoComplete, Inc. is an insurance-technology company located in San Francisco, California, focused on transforming the car insurance market, which is valued at $311 billion. The company has developed an artificial intelligence platform that aims to simplify the auto insurance process, providing users with a streamlined experience. By leveraging AI technology, AutoComplete enables users to obtain auto protection with minimal effort, enhancing the overall customer experience in automotive insurance.
Contextual AI
Series A in 2024
Contextual AI offers a pioneering approach to generative AI for the workplace.
Imperative Care
Series E in 2024
Imperative Care, Inc. is dedicated to enhancing the speed and effectiveness of acute stroke treatment through innovative medical technologies. Founded in 2015 and based in Campbell, California, the company has developed a range of solutions aimed at addressing critical needs in stroke care. Among its offerings is the Large Distal Platform, a large diameter catheter designed to reach treatment sites for both ischemic and hemorrhagic strokes. Complementing this is the ZOOM Aspiration System, a comprehensive solution that works in conjunction with the Large Distal Platform and includes various trackable reperfusion catheters for effective clot removal. By advancing stroke treatment technologies, Imperative Care aims to improve patient outcomes and optimize recovery processes for those affected by strokes.
Somacis
Acquisition in 2024
Somacis SpA specializes in the manufacturing and supply of printed circuit boards (PCBs), including rigid, flex, and rigid-flex types. The company is recognized for its expertise in high-density interconnect (HDI) and flex-rigid PCBs, offering solutions that accommodate up to 50 layers. Somacis provides a range of products such as buried components, metal core solutions, RF/microwave products, graphic overlays, touch screens, and custom membrane switches. Founded in 1972 and headquartered in Castelfidardo, Italy, Somacis operates additional production facilities in Manfredonia, Italy; Poway, California; and Guangdong, China. The company serves various industries, including telecommunications, aerospace, defense, industrial, medical, automotive, and information technology, catering to both time-sensitive and mass production needs.
Kestra Medical Technologies
Private Equity Round in 2024
Kestra Medical Technologies, Inc. specializes in the development and manufacturing of wearable medical devices designed for monitoring and managing acute medical conditions. Founded in 2014 and based in Kirkland, Washington, the company offers solutions that collect, communicate, and store patient performance data, enabling both real-time and retrospective analysis. Among its products are wearable cardioverter defibrillators, which aim to prevent sudden cardiac death and facilitate cardiac recovery in at-risk patients. Kestra Medical Technologies focuses on creating intuitive and mobile diagnostic and therapeutic technologies that support healthcare providers and enhance patient care.
Momento
Series A in 2024
Momento was founded with the vision to enable developers to write reliable and powerful apps faster than ever thought possible. Momento removes the need to manage caches by providing a serverless caching solution that works at any scale, so developers can concentrate on doing what they love: developing better products and services, faster. Momento is a team of distributed systems and database experts. The company is headquartered out of Seattle, Washington with a team that is distributed worldwide. Visit gomomento.com for more information—or see just how fast and simple it is to get going with Momento by starting for free at start.gomomento.com.
MRO Holdings
Private Equity Round in 2024
MRO Holdings is a company that specializes in aircraft maintenance, modifications, and conversions, offering a comprehensive suite of technical solutions for the aviation industry. Its services encompass airframe maintenance, engineering, and the development of maintenance programs and reliability strategies. By focusing on long-term applications within the aircraft maintenance sector, MRO Holdings aims to create a stable and challenging work environment for aviation professionals, emphasizing a strong culture of safety, quality, and performance.
Savara Pharmaceuticals
Post in 2024
Savara is an orphan lung disease company. Savara’s pipeline comprises Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF, in Phase 3 development for autoimmune pulmonary alveolar proteinosis, or aPAP, in Phase 2a development for nontuberculous mycobacteria, or NTM, lung infection, and in preparation for Phase 2a development in cystic fibrosis, or CF, affected individuals with chronic NTM lung infection; and AeroVanc, a Phase 3 stage inhaled vancomycin for treatment of persistent methicillin resistant staphylococcus aureus, or MRSA, lung infection in CF. Savara’s strategy involves expanding its pipeline of potentially best-in-class products through indication expansion, strategic development partnerships and product acquisitions, with the goal of becoming a leading company in its field. The most recent acquisition is aerosolized amikacin/fosfomycin, a Phase 2 ready, proprietary combination antibiotic, which has demonstrated potent and broad-spectrum antibacterial activity against highly drug resistant pathogens. Savara’s management team has significant experience in orphan drug development and pulmonary medicine, identifying unmet needs, developing and acquiring new product candidates, and effectively advancing them to approvals and commercialization.
Pomerium
Series A in 2024
Pomerium is a developer of identity-aware proxy software that enables secure access to internal applications without the need for a virtual private network (VPN). The company's software offers a standardized interface for authenticating, authorizing, and monitoring user access to any application, regardless of whether the application has built-in access control features. This allows enterprises to streamline security processes and focus on application development without the complexities of reinventing access control mechanisms. Pomerium's solutions enhance security while facilitating the use of both internal and external applications efficiently.
Bapcor
Private Equity Round in 2024
Bapcor is a leading provider of automotive aftermarket parts, accessories, and services in Australasia, primarily operating in Australia and New Zealand. The company specializes in the distribution of automotive spare parts through its Trade, Retail & Service, and Specialist Wholesale segments. Its Trade businesses include Burson Auto Parts and BNT, which offer a vast selection of car parts for over 400 vehicle makes and models. In the Retail & Service sector, Bapcor operates brands such as Autobarn, Autopro, and Sprint Auto Parts, catering to the do-it-yourself market, as well as service-oriented businesses like Midas and ABS. Additionally, its Specialist Wholesale segment focuses on providing specialized automotive parts. Through these diverse offerings, Bapcor serves both independent and chain mechanic workshops, establishing itself as a significant player in the automotive aftermarket industry.
Cube Dev
Series B in 2024
Cube Dev, Inc. is a San Francisco-based company that specializes in designing and developing an open-source analytical API platform. The company's offerings include tools for building user interfaces, analytical API servers, and support for modern data stores. Their flagship product, Cube Cloud, serves as a semantic layer that helps organizations manage and optimize their analytics workflows by unifying business logic, centralizing governance and security, and enhancing query performance. Cube Cloud is equipped to handle significant data volumes and provides built-in security, allowing clients to efficiently fetch data rather than relying on pre-built visualizations. Established in 2016, Cube Dev aims to empower businesses to build both internal business intelligence tools and customer-facing analytics capabilities.
CereVasc
Series B in 2024
CereVasc, Inc. is a medical device company dedicated to developing innovative, minimally invasive treatments for neurological diseases. Founded in 2014 and based in Auburndale, Massachusetts, the company focuses on its flagship product, the eShunt System. This system provides an endovascularly deliverable cerebrospinal fluid shunt along with necessary delivery components, designed to eliminate the need for invasive surgical procedures, general anesthesia, and prolonged hospitalization associated with traditional treatments for communicating hydrocephalus. By offering a less invasive option, the eShunt System aims to enhance patient outcomes and reduce the overall costs of surgical interventions for this serious condition.
Sikich
Private Equity Round in 2024
Sikich is a Chicago-based accounting firm established in 1982 that provides a wide range of services, including accounting, auditing, tax planning, and information technology managed services. The firm also has a dedicated investment banking division that specializes in mergers and acquisitions, as well as capital raising for corporations, private equity firms, and entrepreneurs. Sikich serves various sectors, including healthcare and life sciences, agriculture, construction, manufacturing, technology, education, and retail, offering tailored financial and strategic advisory services to meet the unique needs of its clients.
Ansa
Series A in 2024
Ansa develops a closed-loop payment technology that enables marketers to create customer balances and facilitate payments. This platform is designed to enhance customer loyalty by funding accounts and offering insights into consumer spending behaviors. By leveraging this technology, businesses can reduce payment costs, increase transaction values, and encourage repeat purchases, ultimately fostering stronger customer relationships and driving revenue growth.
Prophet Security
Seed Round in 2024
Prophet Security provides security operations by automating the triage, investigation, and response process.
Century Therapeutics
Post in 2024
Century Therapeutics, Inc. is a biotechnology company focused on developing innovative cell therapies derived from induced pluripotent stem cells (iPSCs) to treat hematologic and solid malignancies. Founded in 2018 and headquartered in Philadelphia, Pennsylvania, the company utilizes a specialized platform that integrates gene editing and protein engineering to create allogeneic therapies. This platform allows for the generation of master cell banks of modified immune effector cells, specifically engineered to optimize performance and reduce the risk of rejection by the host immune system. By employing advanced technologies such as CRISPR-mediated gene editing and proprietary chimeric antigen receptors, Century Therapeutics aims to address significant unmet medical needs in cancer and other diseases.
Homebase
Series D in 2024
Homebase is a developer of employee management software focused on simplifying the administrative tasks associated with hourly work. The platform offers tools for scheduling, time tracking, and communication, all designed to minimize the burden on employers and employees alike. Its cloud-based system allows users to manage timesheets and track hours from any location, facilitating efficient payroll preparation. While the basic features are available for free, Homebase also provides tiered pricing options for businesses seeking additional functionalities. By streamlining these processes, Homebase aims to help organizations save time and improve coordination among their teams.
Xilio Therapeutics
Post in 2024
Xilio Therapeutics is a clinical-stage biotechnology company focused on developing innovative immunotherapies to enhance the immune system's ability to combat cancer. The company specializes in tumor-selective immunotherapies that leverage its proprietary technology to maximize the effectiveness of existing immuno-oncology treatments while minimizing side effects outside the tumor. Its lead product, XTX201, is designed to induce immune activity specifically within tumors, demonstrating improved antitumor efficacy. Xilio Therapeutics aims to deliver significant improvements in patient outcomes by utilizing its platform to create a pipeline of novel therapies, including tumor-activated cytokines, antibodies, and immune cell engagers, all targeted to optimize therapeutic effects within the tumor microenvironment. Founded in 2015 and based in Waltham, Massachusetts, the company was previously known as Akrevia Therapeutics before rebranding in March 2020.
Gather AI
Series A in 2024
Gather AI is a Pittsburgh-based company founded in 2017 that offers an autonomous inventory management platform tailored for modern warehouses. The company specializes in providing a comprehensive inventory service that integrates its artificial intelligence-based software with off-the-shelf drones, allowing users to automate inventory tasks efficiently. Gather AI's solution operates safely in environments lacking GPS, enabling real-time data analytics and inventory monitoring. The team consists of experts, including PhDs and research engineers from the Carnegie Mellon Robotics Institute, focusing on autonomous vehicles and vision systems. By utilizing Gather AI’s services, businesses can optimize their operations and enhance inventory management processes.
Loyal
Series B in 2024
Loyal is a biotechnology company focused on developing veterinary pharmaceuticals aimed at extending the lifespan and improving the health span of dogs. By creating medications that target the aging process, Loyal seeks to delay or prevent the onset of age-related diseases, including cancer, heart disease, and metabolic disorders. The company's innovative approach involves quantifying and regulating the biological processes associated with aging, which helps to mitigate the severity of these ailments. Through its research and product development, Loyal strives to ensure that dogs can enjoy longer, healthier lives, ultimately benefiting both pets and their owners.
Unstructured
Series B in 2024
Unstructured is a developer of an open-source data transformation platform that simplifies the process of converting raw data from various sources, such as PDFs and Microsoft Office documents, into formats suitable for retrieval-augmented generation (RAG) applications. The platform supports over 25 file types and offers integration capabilities with third-party services like SharePoint and S3. By utilizing open-source libraries and application programming interfaces, Unstructured allows clients to create custom preprocessing pipelines tailored for machine learning tasks. This capability enhances the accessibility of human-generated information for large language models (LLMs) and facilitates seamless data extraction and integration into AI workflows, ultimately enabling organizations to maximize the value of their documents.
Fermat Commerce
Series A in 2024
Fermat Commerce operates an influencer-driven e-commerce platform designed to enhance brand sales and provide a seamless shopping experience for end-users. The platform enables content creators to embed brand-direct shopping features on their websites, allowing customers to purchase products without leaving the creators' content. By offering e-commerce enablement software, Fermat Commerce supports both merchants and content creators in building and managing their online stores, thereby facilitating a direct connection between brands and consumers within a creator's online environment.
Argyle
Series C in 2024
Argyle develops a payroll connectivity platform that enhances financial services by providing real-time income and employment data. The platform automates various processes, including verifications, background checks, account funding, direct deposit switching, premium calculations, and wage advancements. By streamlining these functions, Argyle enables businesses and financial institutions to improve their onboarding and account management processes, thereby facilitating modern financial solutions.
Relay
Series B in 2024
Relay is an-all-in-one, collaborative business banking and money management platform that helps small businesses and their teams take control of their cash flow and get crystal clear on what they’re earning, spending and saving. With Relay, business owners can: -Bank with no monthly account fees, no overdraft fees, and no minimum balance required -Organize income, expenses and cash reserves using up to 20 individual accounts -2 savings accounts offering between 1-3% APY -Issue up to 50 virtual or physical Visa® debit cards to meticulously organize spending by team or project -Send payments and deposits via ACH, wires or checks -Cashflow automations, like maximum balance transfer rules and recurring payments -Give team members and financial advisors secure, role-based banking access -Integrate banking with accounting softwares like QuickBooks Online and Xero -Get personalized customer support by email and phone Relay is also the official banking partner of Profit First, the cash flow management methodology and book created by serial entrepreneur Mike Michalowicz.
GigEasy
Pre Seed Round in 2024
GigEasy is building an Insurance and Benefits platform to power the GigEconomy.
Areteia Therapeutics
Series A in 2024
Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.
Navro
Venture Round in 2024
Navro specializes in providing payment and banking infrastructure tailored for software companies. The company has developed a fintech platform that enables brands to scale their payment operations on a global scale. Navro offers a range of services, including customizable checkout solutions, integration of various payment acceptance methods, local fund collection, and real-time payment stack management. This comprehensive approach allows businesses to efficiently manage their payments infrastructure, facilitating international growth and ensuring that companies can receive funds in their preferred methods.
Branching Minds
Private Equity Round in 2024
Branching Minds, Inc. offers a web-based platform designed to assist educators in identifying and addressing students' learning challenges. Founded in 2013 and based in New York, the company's tool enables teachers and parents to gather data on students’ observable behaviors through a structured Q&A process, helping to pinpoint cognitive issues and strengths. The platform algorithmically matches students with research-backed learning supports and allows users to track observations, systematize record-keeping, and generate reports. By integrating learning sciences with artificial intelligence technology, Branching Minds empowers intervention teams and classroom teachers to effectively understand the root causes of students' difficulties, ultimately enhancing the response to intervention and multi-tier systems of support in educational settings.
Accolade Wines
Acquisition in 2024
Accolade Wines is a global wine business headquartered in South Australia. It is recognized as the leading wine company in both Australia and the UK by volume, and ranks fifth among wine companies worldwide. Established with one of the first wineries in Australia, Accolade Wines has a rich history dating back to 1853. The company specializes in the production and distribution of a diverse range of well-known wine brands, reflecting its commitment to quality and innovation in the wine industry.
Solid Biosciences
Post in 2024
Solid Biosciences Inc. is a life science company focused on developing therapies for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys. The company's lead product candidate, SGT-001, is a gene transfer therapy currently undergoing a Phase I/II clinical trial aimed at restoring functional dystrophin protein expression in patients' muscles. In addition to SGT-001, Solid Biosciences is advancing the Anti-LTBP4 program, which involves a monoclonal antibody designed to reduce fibrosis and inflammation by targeting the LTBP4 protein. The company also develops biomarkers and sensors, as well as the Solid Suit program, which focuses on creating wearable assistive devices with functional and therapeutic benefits. Founded in 2013 and headquartered in Cambridge, Massachusetts, Solid Biosciences has established a strategic collaboration with Ultragenyx to enhance gene therapy development for DMD. With no current cure for DMD, the company aims to provide innovative solutions for a condition that affects an estimated 10,000 to 15,000 cases in the United States.
Avistone Pharmaceuticals
Series B in 2023
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
Halcyon
Series B in 2023
Halcyon is a cybersecurity company focused on protecting enterprise clients from ransomware threats. It provides a platform that integrates layered ransomware protection, utilizing pre-execution detection, behavioral modeling, and deception techniques. This comprehensive approach aims to enhance the resilience of its clients, facilitating recovery and isolation of affected nodes. Halcyon primarily serves mid-market and enterprise customers, ensuring they are equipped to mitigate the risks associated with ransomware attacks.
Syros Pharmaceuticals
Post in 2023
Syros Pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. Syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical R&D. Central to the Syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of Syros' senior leadership. While this scientific approach has applications in many therapeutic areas, Syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.
1440 Foods Company
Acquisition in 2023
1440 Foods Company is dedicated to fostering a healthier community by offering a diverse portfolio of sports and active nutrition products. The company specializes in health and wellness brands that provide efficacy-driven protein powders, meal replacements, and lifestyle products aimed at promoting balanced nutrition. Through its focus on powerful and complementary growth brands, 1440 Foods seeks to inspire individuals to realize their potential and enhance their overall well-being.
Andalusia Labs
Series A in 2023
Andalusia Labs is focused on developing essential digital infrastructure tailored for internet markets, particularly in the realm of digital assets. The company offers a comprehensive platform that includes a security solution and risk management infrastructure specifically designed for the blockchain sector. This platform facilitates the management of significant amounts of digital assets, providing innovative companies worldwide with the tools necessary to navigate the complexities of risk associated with digital transactions. Through its offerings, Andalusia Labs aims to enhance the security and efficiency of the digital asset marketplace.
Eleda Group
Acquisition in 2023
Eleda Group offers installation and contract services in infrastructure via companies that are local leaders. The Group’s offering is both broad and specialized, ranging from complete contracts and projects to leasing machinery, with a focus on three service areas: Civil Engineering, Transmission Infrastructure and Machinery and Transportation.
MaintainX
Series C in 2023
MaintainX, Inc. is a technology company that specializes in a frontline record management platform designed for maintenance and facility management teams. Launched in 2018 and based in San Francisco, California, MaintainX provides a software as a service (SaaS) solution that digitizes workflows, enhances collaboration, and offers analytics to streamline maintenance operations. The platform includes features such as environmental and training checklists, tooling and gauge reporting, auditing workflows, and quality control inspections. Additionally, it facilitates communication among users and allows for photo uploads to enhance operational efficiency. MaintainX serves a diverse range of industries, including manufacturing facilities, restaurants, and hotels, focusing on improving asset management and ensuring regulatory compliance.
Eyebiotech
Series A in 2023
Eyebiotech is a vision treatment company that develops products to preserve, repair, and improve eyesight. The firm guards against sight-threatening eye disorders and developed the first anti-vascular endothelial growth factor medication for patients with age-related macular degeneration, allowing those with eye ailments to regain their eyesight.
Gynesonics
Venture Round in 2023
Gynesonics, Inc. is a medical device company that focuses on designing and developing minimally invasive solutions for symptomatic uterine fibroids in women. Established in 2005 and headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands, the company offers the Sonata System, which utilizes sonography-guided transcervical fibroid ablation for the treatment of fibroids under intrauterine sonography guidance. Gynesonics aims to provide a safe and effective incisionless alternative to traditional surgical techniques such as hysterectomy and myomectomy, thereby enabling women to receive painless treatments for severe menstrual symptoms associated with fibroids.
Aiolos Bio
Series A in 2023
Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to-severe asthma that only requires dosing every 6 months. Aiolos Bio was founded by an accomplished team with decades of drug development experience and leadership in the biotech industry.
Aleph
Series A in 2023
Aleph operates a financial planning and analysis platform designed to enhance the capabilities of traditional spreadsheets such as Excel and Google Sheets. By integrating data from accounting systems and various operational sources, Aleph provides specialized financial tools that are always current. This allows clients to create sophisticated financial models and use cases, ultimately facilitating informed investment decisions. Aleph aims to support finance departments by merging the familiarity of spreadsheets with advanced financial insights, making it a valuable resource for financial professionals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.